pharmaphorum

FDA’s emerging framework to reduce animal testing: Implications for drug development timelines, cost, and clinical strategy

The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...
Opinion
Physicians Committee for Responsible MedicineOpinion

Making Animal Experiments the Exception: The Physicians Committee’s Road to FDA Reform

In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...
PharmTech

Accelerating Discovery and Development with Advances in High-Throughput Screening

Automation, miniaturization, and new software algorithms are improving throughput and accuracy. High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological ...
American Council on Science and HealthOpinion

Holiday Gift for the Animals

A rare moment of bipartisan progress has emerged with the Senate’s unanimous passage of the FDA Modernization Act 3.0, ...
FierceBiotech

FDA plans to end animal testing requirements for monoclonal antibody drugs

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...
Forbes

The Distinction Between Testing And Quality Assurance In The Software Industry

Although it is sometimes thought that quality assurance (QA) and software testing are the same, they are, in fact, different concepts. They differ in their objectives, features and methods. Testers ...